205 related articles for article (PubMed ID: 24162331)
1. Surgical outcomes for 131 cases of carcinosarcoma of the hepatobiliary tract.
Okabayashi T; Shima Y; Iwata J; Iiyama T; Sumiyoshi T; Kozuki A; Tokumaru T; Hata Y; Noda Y; Morita M
J Gastroenterol; 2014 Jun; 49(6):982-91. PubMed ID: 24162331
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic Features and Surgical Outcomes of Neuroendocrine Carcinoma of the Gallbladder.
Tanioka N; Okabayashi T; Sui K; Matsumoto T; Iwata J; Morita S; Shimada Y
Surg Technol Int; 2019 May; 34():101-106. PubMed ID: 30888678
[TBL] [Abstract][Full Text] [Related]
3. [Clinical manifestation and prognosis of the surgical treatment of esophageal carcinosarcoma].
Zhang BH; Yang WJ; Wang YG; Zhang HT
Zhonghua Wai Ke Za Zhi; 2012 Mar; 50(3):256-9. PubMed ID: 22800752
[TBL] [Abstract][Full Text] [Related]
4. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.
Nanashima A; Yamaguchi H; Sumida Y; Abo T; Tobinaga S; Tanaka K; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(84):873-8. PubMed ID: 18705286
[TBL] [Abstract][Full Text] [Related]
5. Primary hepatic sarcomatoid carcinoma: clinical features and prognosis of 28 resected cases.
Lu J; Zhang J; Xiong XZ; Li FY; Ye H; Cheng Y; Zhou RX; Lin YX; Cheng NS
J Cancer Res Clin Oncol; 2014 Jun; 140(6):1027-35. PubMed ID: 24647927
[TBL] [Abstract][Full Text] [Related]
6. Surgical outcome of carcinosarcoma of the gall bladder: a review.
Okabayashi T; Sun ZL; Montgomey RA; Hanazaki K
World J Gastroenterol; 2009 Oct; 15(39):4877-82. PubMed ID: 19842216
[TBL] [Abstract][Full Text] [Related]
7. Surgical Treatments of Hepatobiliary Cancers.
Gunasekaran G; Bekki Y; Lourdusamy V; Schwartz M
Hepatology; 2021 Jan; 73 Suppl 1():128-136. PubMed ID: 32438491
[TBL] [Abstract][Full Text] [Related]
8. Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification.
Shimizu H; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Mitsuhashi N; Takeuchi D; Suda K; Yoshioka I; Miyazaki M
J Hepatobiliary Pancreat Surg; 2007; 14(4):358-65. PubMed ID: 17653633
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases.
Huang SY; Shen SJ; Li XY
World J Surg Oncol; 2013 Oct; 11():252. PubMed ID: 24088577
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and prognosis of three rare and poor-prognostic subtypes of primary liver carcinoma].
Li Z; Huang Z; Bi X; Yang L; Zhao J; Zhao H; Zhang Y; Cai J; Zheng X
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):207-11. PubMed ID: 24785282
[TBL] [Abstract][Full Text] [Related]
11. Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study.
Song A; Eo W; Kim S; Shim B; Lee S
BMC Complement Altern Med; 2018 Jun; 18(1):176. PubMed ID: 29879960
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.
Şükür YE; Taşkın S; Varlı B; Ateş C; Güngör M; Ortaç F
Int J Clin Oncol; 2018 Feb; 23(1):114-120. PubMed ID: 28836024
[TBL] [Abstract][Full Text] [Related]
13. Comparison of minimally invasive versus open surgery in the treatment of endometrial carcinosarcoma.
Pedra Nobre S; Mueller JJ; Gardner GJ; Long Roche K; Brown CL; Soslow RA; Alektiar KM; Sonoda Y; Broach VA; Jewell EL; Zivanovic O; Chi DS; Abu-Rustum NR; Leitao MM
Int J Gynecol Cancer; 2020 Aug; 30(8):1162-1168. PubMed ID: 32690592
[TBL] [Abstract][Full Text] [Related]
14. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged.
Alabraba E; Joshi H; Bird N; Griffin R; Sturgess R; Stern N; Sieberhagen C; Cross T; Camenzuli A; Davis R; Evans J; O'Grady E; Palmer D; Diaz-Nieto R; Fenwick S; Poston G; Malik H
Eur J Surg Oncol; 2019 Sep; 45(9):1660-1667. PubMed ID: 31014988
[TBL] [Abstract][Full Text] [Related]
15. Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes.
Garg G; Shah JP; Kumar S; Bryant CS; Munkarah A; Morris RT
Int J Gynecol Cancer; 2010 Jul; 20(5):888-94. PubMed ID: 20606539
[TBL] [Abstract][Full Text] [Related]
16. Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies.
Schneider EB; Hyder O; Wolfgang CL; Hirose K; Choti MA; Makary MA; Herman JM; Cameron JL; Pawlik TM
J Am Coll Surg; 2012 Nov; 215(5):607-15. PubMed ID: 22921328
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of uterine carcinosarcoma: results of 94 patients.
Gokce ZK; Turan T; Karalok A; Tasci T; Ureyen I; Ozkaya E; Kose MF; Tulunay G
Int J Gynecol Cancer; 2015 Feb; 25(2):279-87. PubMed ID: 25611900
[TBL] [Abstract][Full Text] [Related]
18. Carcinosarcoma of the ovary-a case series.
Rutledge TL; Gold MA; McMeekin DS; Huh WK; Powell MA; Lewin SN; Mutch DG; Johnson GA; Walker JL; Mannel RS
Gynecol Oncol; 2006 Jan; 100(1):128-32. PubMed ID: 16213011
[TBL] [Abstract][Full Text] [Related]
19. Association of preoperative biliary drainage technique with postoperative outcomes among patients with resectable hepatobiliary malignancy.
Hu QL; Liu JB; Ellis RJ; Liu JY; Yang AD; D'Angelica MI; Ko CY; Merkow RP
HPB (Oxford); 2020 Feb; 22(2):249-257. PubMed ID: 31350104
[TBL] [Abstract][Full Text] [Related]
20. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]